Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
神経障害治療用のリーリン組成物
Document Type and Number:
Japanese Patent JP7253800
Kind Code:
B2
Abstract:
Changes in Reelin levels as well as Reelin signaling alter cognitive function. This can be accomplished by administering a therapeutically effective amount of a repeat fragment of Reelin, or a construct formed from fragment repeats of Reelin to a patient or subject. Changes to Reelin levels can be used to treat various neurodegenerative diseases, neuronal insults, or stroke, such as fragile X syndrome, William's syndrome, Rett syndrome, Down's syndrome, Angelman syndrome, autism, ischemia, hypoxia, Alzheimer's disease, and schizophrenia. Reelin can also be used to alter dendritic spine density, diminished long-term potentiation, and diminished synaptic plasticity and associative learning deficits. Constructs formed from repeat region 3 of full length Reelin and repeat region 5 of full length Reelin, or repeat region 3 of full length Reelin and repeat region 6 of full length Reelin have been found particularly useful.

Inventors:
Weaver, Edwin Jae
Application Number:
JP2019505258A
Publication Date:
April 07, 2023
Filing Date:
August 03, 2017
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
University of South Florida
International Classes:
A61K35/76; A61K48/00; A61P25/00; A61P25/18; A61P25/24; A61P25/28; A61P43/00
Domestic Patent References:
JP2016503405A
JP2015520161A
Foreign References:
WO2015013148A2
WO2016100575A1
Other References:
European Journal of Neuroscience,2015年,41,p.1372-1380
Frontiers in Cellular Neuroscience,2016年03月,10,Article75,p.1-8
Database GenBank: AAC51105.1,1997年02月24日,DeSilvia,U.et al.,DEFINITION:reelin [Homo sapiens], retrieved on 07.Jan.2022
Attorney, Agent or Firm:
Takahiro Ozaki